/PRNewswire/ Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a.
A new report published by Future Market Insights (FMI) projects that the global pigmented lesion treatment market will witness an above-average CAGR between 2017 and 2022 to reach a valuation of US$ 375 Mn.In the past couple of years, demand for pigment lesion treatment has increased to a significant extent. Pigment.
New York, NY (PRWEB) May 02, 2022 Viora Inc., a global leader in manufacturing and distributing medical aesthetic technology, announced the appointment of